跳至主要内容
临床试验/KCT0001081
KCT0001081已完成未知

A comparison of clinical outcomes between cefazolin and nafcillin therapy for methicillin-susceptible Staphylococcus aureus bacteremia

Seoul National University Bundang Hospital0 个研究点目标入组 400 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • Among all adult (>=18years) patient with MSSA bacteremia at participating hospitals was ascertained during the study period
  • 1) Patient who received cefazolin or nafcillin as definite antibiotics
  • 2) Patient who agree the gathering clinical information about S. aureus bacteremia by inform consent.
  • 3) Patient who fulfill the criteria of waiver of informed consent: Patient who died or transferred within 2 weeks after the onset of bacteremia was waived by institutional review board.

排除标准

  • Patient who do not agree the participation in this study, except for patient who fulfill the criteria of waiver of informed consent.

研究者

相似试验